CIK 0001831097 · Large accelerated filer
agilon health, inc.
Sign in to watch- Ticker
- AGL
- Exchange
- NYSE
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371915147
- Phone
- 562-256-3800
- Business address
- 440 POLARIS PARKWAY, SUITE 550, WESTERVILLE, OH, 43082
- Former names
- Agilon Health Topco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-14 | Shaker Benjamin Chief Markets Officer | Sale | −73,018 | $28.98 | $2.1M | 113,586 |
| 2021-09-14 | Shaker Benjamin Chief Markets Officer | Option exercise · Options (Rights to Buy) | −73,018 | 376,982 | ||
| 2021-09-14 | Sell Steven CEO & President | Option exercise | +100,000 | $4.50 | $450K | 100,000 |
| 2021-09-14 | Sell Steven CEO & President | Sale | −100,000 | $28.98 | $2.9M | 0 |
| 2021-09-14 | Sell Steven CEO & President | Option exercise · Options (Rights to Buy) | −100,000 | 900,000 | ||
| 2021-09-14 | Mansukani Sharad Director | Option exercise | +156,250 | $1.00 | $156K | 1,385,606 |
| 2021-09-14 | Mansukani Sharad Director | Sale | −156,250 | $28.98 | $4.5M | 1,229,356 |
| 2021-09-14 | Mansukani Sharad Director | Option exercise · Options (Rights to Buy) | −156,250 | 493,750 | ||
| 2021-09-14 | Kornitzer Benjamin Chief Med. & Quality Officer | Option exercise | +11,475 | $4.50 | $52K | 16,909 |
| 2021-09-14 | Kornitzer Benjamin Chief Med. & Quality Officer | Sale | −11,475 | $28.98 | $333K | 5,434 |
| 2021-09-14 | Kornitzer Benjamin Chief Med. & Quality Officer | Option exercise · Options (Rights to Buy) | −11,475 | 538,525 | ||
| 2021-09-14 | Halkias Theodore Chief Business Officer | Option exercise | +58,553 | $1.00 | $59K | 63,987 |
| 2021-09-14 | Halkias Theodore Chief Business Officer | Sale | −58,553 | $28.98 | $1.7M | 5,434 |
| 2021-09-14 | Halkias Theodore Chief Business Officer | Sale | −100,000 | $28.98 | $2.9M | 0 |
| 2021-09-14 | Halkias Theodore Chief Business Officer | Option exercise · Options (Rights to Buy) | −58,553 | 1,741,447 | ||
| 2021-09-14 | Dombro Lisa Exper. & Innovation Officer | Option exercise | +61,543 | $1.00 | $62K | 73,499 |
| 2021-09-14 | Dombro Lisa Exper. & Innovation Officer | Sale | −61,543 | $28.98 | $1.8M | 11,956 |
| 2021-09-14 | Dombro Lisa Exper. & Innovation Officer | Option exercise · Options (Rights to Buy) | −61,543 | 438,457 | ||
| 2021-09-14 | Desai Veeral Chief Strategy & Dev. Officer | Option exercise | +121,001 | $1.00 | $121K | 382,957 |
| 2021-09-14 | Desai Veeral Chief Strategy & Dev. Officer | Sale | −121,001 | $28.98 | $3.5M | 261,956 |
Page 29 of 31 · 615 trades